Stock listing
Marizyme, Inc.
Selected listing: MRZM · OTC · USD · US
Marizyme, Inc. (OTC:MRZM), Health Technology. Latest release Apr 16, 2024: Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics…
- Ticker
- OTC:MRZM
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
About Marizyme, Inc.
The company focuses on developing innovative solutions in the healthcare sector. Investors can find detailed information about Marizyme's operations and performance on their public company page.
Latest news from Marizyme, Inc.
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
April 15, 2024
Marizyme CEO Delivers Business Update
October 22, 2023
The Watchlist by The Market Herald Releases New Interviews with Marizyme, Regenx, BuildDirect, and Three Sixty Solar Discussing Their Latest News
October 5, 2023
Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft™
October 5, 2023
Marizyme Announces IP Developments for DuraGraft® and Its Pipeline Products
May 9, 2023